Tendencias en la investigación del virus de papiloma humano en Latinoamérica frente a los países de altos ingresos

  • Jeel Junior Moya-Salazar Hospital Nacional Docente Madre Niño San Bartolomé, Lima Perú
  • Victor Rojas-Zumaran Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Perú

Resumen

Objetivo: este documento busca hacer una reflexión sobre las tendencias en la investigación del Virus de Papiloma Humano (VPH) en Latinoamérica en comparación con los países de altos-ingresos.

Materiales y métodos: con base en la evaluación de estudios desarrollados en diversos países, discriminados por el grado de desarrollo económico y social, se da respuesta a preguntas  relacionadas con el VPH en cuanto a: su frecuencia,  las tendencias de investigación, los programas de educación al personal de salud y los pacientes,   y las estrategias preventivas. Para esto se realizó una extensa revisión  de las investigaciones publicadas y los estudios presentados en el I Encuentro Sudamericano del VPH.

Resultados: los esfuerzos para el desarrollo de investigación sobre VPH se reflejan en estudios básicos y aplicados sobre VPH y cancer cervicouterino (CCU). Existen limitaciones en el desarrollo científico regional comparado con los países de ingresos altos que se evidencian en las tasas de prevalencia y vacunación. Se observan transformaciones lentas en los programas de prevención en cada nivel, con dificultades de índole regional.

Conclusión: el impacto del VPH y del CCU es inconmensurable para Latinoamérica, lo que exige el desarrollo de políticas públicas e intervenciones preventivas y organizadas.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Jeel Junior Moya-Salazar, Hospital Nacional Docente Madre Niño San Bartolomé, Lima Perú
Facultad de Ciencias de la Salud, Universidad Continental de Huancayo. Área de Citología, Servicio de Patología, Hospital Nacional Docente Madre-Niño San Bartolomé, Lima (Perú). jeel.moyasalazar@icloud.com
Victor Rojas-Zumaran, Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Perú
Facultad de Ciencias de la Salud, Universidad Continental de Huancayo. Área de Citología, Servicio de Patología, Hospital Nacional Docente Madre-Niño San Bartolomé, Lima (Perú).

Referencias bibliográficas

Ali F, Kuelker R, Wassie B. Understanding cervical cancer in the context of developing countries. Ann Trop Med PH. 2012;5:3-15. https://doi.org/10.4103/1755-6783.92871

de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607-15. https://doi.org/10.1016/S1470-2045(12)70137-7

Moya SJ, Pio DL. Prevalence of cervical- uterine abnormalities associated with poverty levels at "Hospital Nacional Docente Madre Ni-o San Bartolome" between 2011- 2013. Rev Invest Univ Norbert Wiener 2014;3:89-99.

Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008;113:2855-64. https://doi.org/10.1002/cncr.23756

Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, et al. Cervical Cancer Behavioral Factors Related to Screening, Diagnosis, and Survivors' Quality of Life. Cancer 2003; 98 Suppl 9:2009-14. https://doi.org/10.1002/cncr.11681

Fernández de Casadevante V, Gil Cuesta J, Cantarero-Arévalo L. Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies. Front. Oncol. 2015;5:1-13. https://doi.org/10.3389/fonc.2015.00141

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis. Lancet 2011;378:1461-84. https://doi.org/10.1016/S0140-6736(11)61351-2

Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-65. https://doi.org/10.1136/jcp.55.4.244

zur Hansen H. Infections Causing Human Cancer. Weinheim: Wiley-VCH; 2006. https://doi.org/10.1002/3527609318

Ibáñez R, Autonell A, Sardà M, Crespo N, Pique P, Pascual A, et al. Protecting the underscreened women in developed countries: the value of HPV test. BMC Cancer 2014;14:574. https://doi.org/10.1186/1471-2407-14-574

Norrild B. The 22nd International Papillomavirus Conference and Clinical Workshop 2005: Highlights from the molecular biology sessions. Papillomavirus Report 2005;16: 203-5. https://doi.org/10.1179/095741905X49061

Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Mu-oz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 27 July 2017.

McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER., Paulose-Ram R. Prevalence of HPV in adults aged 18–69: United States, 2011–2014. NCHS data brief, nº 280. Hyattsville, MD: National Center for Health Statistics. 2017. [visitado 2017 Jul 30]; Disponible en: https://www.cdc.gov/nchs/data/databriefs/db280.pdf

International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-21. https://doi.org/10.1016/S0140-6736(07)61684-5

Bondi VLP, Tosato BNA, Bueno de Freitas L, Espinosa MA, Cruz SL. The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results. PLoS One. 2017;12:e0176422. https://doi.org/10.1371/journal.pone.0176422

Hartwiga S, Baldauf J, Dominiak-Feldena G, Simondon F, Alemany L, de Sanjosé S, et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res. 2015;1:90-100. https://doi.org/10.1016/j.pvr.2015.06.003

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC, Cancer Base No.11 [Internet]. Lyon: International Agency for Research on Cancer. 2013.

Hindryckx P, Garcia A, Claeys P, Gonzalez C, Velasquez R, Bogers J, et al. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix. Sex Transm Infect. 2006;82:334-6. https://doi.org/10.1136/sti.2006.019745

Brebi MP, Ili CG, López MJ, García MP, Melo AA, Montenegro HS, et al. Detección y tipificación de virus papiloma humano en adenocarcinoma de cuello uterino mediante reverse line blot, Región de La Araucanía, Chile. Rev méd Chile 2009;137:377-82. https://doi.org/10.4067/S0034-98872009000300008

Teran CC. Prevalencia y factores asociados a la infección por el virus del papiloma humano (VPH) y las lesiones causadas por el mismo en mujeres de 20 a 59 a-os en el Municipio de Sucre, Bolivia. [Tesis] España: Universidad de Alcalá, Escuela de Doctorado; 2014.

Machado AP, Gatto de Almeida F, Bonin CM, Prata MTT, Ávilla SL, Padovani JCT, et al. Presence of highly oncogenic human papillomavirus in the oral mucosa of asymptomatic men. Braz J Infect Dis. 2014;18:266-70. https://doi.org/10.1016/j.bjid.2013.07.013

Toro de Méndez M, Ferrández A, Llombart A. Diagnóstico precoz del cáncer de cuello uterino asociado a la infección por virus papiloma humano. Acta Cient Soc Venez Bioanalistas Esp. 2013;16:41-53

Valles X, Murga GB, Hernandez G, Sabido M, Chuy A, Lloveras B, et al. High prevalence of human papillomavirus infection in the female population of Guatemala. Int J Cancer. 2009;125:1161-7. https://doi.org/10.1002/ijc.24444

Castro FA, Dominguez A, Puschel K, Van De Wyngard V, Snijders PJF, Franceschi S, et al. Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile. BMC Infectious Diseases 2014;14:361. https://doi.org/10.1186/1471-2334-14-361

Borges GM, Goldenberg P. HPV vulnerability among women who make sex with women. Proceedings from the 21º Congress of the World Association for Sexual Health, J Sex Med 2013;10 (suppl 5):383.

Rodrigues de Oliveira G, Corrêa VV, Martínez MF, DöwichIII V, Alves SM, Vitola CC, et al. Fatores de risco e prevalência da infecção pelo HPV em pacientes de Unidades Básicas de Saúde e de um Hospital Universitário do Sul do Brasil. Rev Bras Ginecol Obstet. 2013;35:226-32. https://doi.org/10.1590/S0100-72032013000500007

Veitía D, de Guglielmo Z, Ávila M, Liuzzi J, Correnti M. Detección de VPH y expresión de p53 en carcinoma de cabeza y cuello. Rev Venez Oncol. 2009;21:123-13.

Chouhy D, D'Andrea RM, Iglesias M, Messina A, Ivancovich JJ, Cerda B, et al. Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National vaccination program. J Med Virol. 2013;85:655-66. https://doi.org/10.1002/jmv.23509

Iwasaki R, Galvez-Philpott F, Arias-Stella J Jr, Arias-Stella J. Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru. Braz J Infect Dis. 2014;18:469-72. https://doi.org/10.1016/j.bjid.2014.01.010

Aguilar PD, Loján GC, Córdova RA, Acurio PK, Arévalo AP, Bobokova A. Prevalence of High-Risk Genotypes of Human Papillomavirus: Women Diagnosed with Premalignant and Malignant Pap Smear Tests in Southern Ecuador. Infect Dis Obstet Gynecol. 2017, Article ID 8572065.

Balanda M, Strauch G, Ramírez E. 0-39 Diagnóstico de infección por virus papiloma humano en pacientes masculinos homosexuales infectados con VIH. Poster. 25-27 Mayo, 2011. X Jornadas Científicas. Instituto de Salud Pública de Chile, Marathon 1.000, Ñu-oa, Santiago, Chile, 2011.

Santos C, Munoz N, Klug S, Almonte M, Guerrero I, Alvarez M, et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer. 2001;85:966. https://doi.org/10.1054/bjoc.2001.1948

Sullcahuaman-Allende Y, Castro-Mujica M, Mejía Farro R, Castaneda CA, Castillo M, Dolores-Cerna K, et al. Características sociodemográficas de mujeres peruanas con virus papiloma humano detectado por PCR-RFLP. Rev Peru Med Exp Salud Publica. 2015;32:509-14. https://doi.org/10.17843/rpmesp.2015.323.1684

Cervantes J, Lema C, Hurtado L, Andrade R, Quiroga G, Garcia G, et al. Prevalence of human papillomavirus infection in rural villages of the Bolivian Amazon. Rev Inst Med Trop Sao Paulo. 2003;45:131-5. https://doi.org/10.1590/S0036-46652003000300003

Torres LM, Paez M, Insaurralde A, Rodriguez MI, Castro A, Kasamatsu E. Detection of high risk human papillomavirus cervical infections by the hybrid capture in Asuncion, Paraguay. Braz J Infect Dis. 2009;13:203-6. https://doi.org/10.1590/S1413-86702009000300009

Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, et al. Popula tion-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004;13:2271-6.

Berois N, Heard I, Fort Z, Alonso R, Sica A, Moerzinger P, et al. Prevalence of type-specific HPV infection in Uruguay. J Med Virol. 2014;86:647-52. doi: 10.1002/jmv.23870. https://doi.org/10.1002/jmv.23870

Fernandes JV, Meissner Rde V, Carvalho MG, Fernandes TA, Azevedo PR, de Azevedo JW, et al. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil. Mol Med Report. 2011;4:1321-6.

de Oliveira GR, Vieira VC, Ávila EC, Finger-Jardim F, Caldeira TDM, Gatti FAA. Human papillomavirus type distribution and HPV16 intratype diversity in southern Brazil in women with and without cervical lesions. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2017; 112:492-8. https://doi.org/10.1590/0074-02760160530

Adenis A, Dufit V, Douine M, Corlin F, Ayhan G, Naijioullah G, et al. High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study. Epidemiol. Infect. 2017;145:1276-84. https://doi.org/10.1017/S0950268816003319

Tabora N, Bulnes R, Toro LA, Claros JM, Massuger LF, Quint WG, et al. Human papillomavirus infection in Honduran women with cervical intraepithelial neoplasia or cervical cancer. J Low Genit Tract Dis. 2011;15:48-53. https://doi.org/10.1097/LGT.0b013e3181e64fdf

Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1796-807. https://doi.org/10.1086/428850

Gonzalez-Andrade F, Sanchez D. HPV genotyping in anogenital abnormal samples of Ecuadorian women. Cancer Biomark. 2009;5:225-32. https://doi.org/10.3233/CBM-2009-0107

Mendoza LP, Arbiza J, Paez M, Kasamatsu E, Castro A, Giménez G, Basiletti J, et al. Distribution of Human Papillomavirus Genotypes in Paraguayan Women According to the Severity of the Cervical Lesion. J Med Virol. 2011;83:1351-7. https://doi.org/10.1002/jmv.22112

Ortiz AP, Romaguera J, Pérez CM, Otero Y, Soto-Salgado M, Méndez K, et al. Human Papillomavirus Infection in Women in Puerto Rico: Agreement between Physician-Collected and Self-Collected Anogenital Specimens. Journal of Lower Genital Tract Disease. 2013;17:210-7. https://doi.org/10.1097/LGT.0b013e318260e312

Figueroa JP, Wards E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD. Prevalence of Human Papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis. 1995;22:114-8. https://doi.org/10.1097/00007435-199503000-00007

Andall-Brereton G, Brown E, Slater S, Holder Y, Luciani S, Lewis M, et al. Prevalence of high-risk human papillomavirus among women in two English-speaking Caribbean countries. Rev Panam Salud Publica 2017;41:e41.

Del Río-Ospina L, Soto-De León SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS ONE 2016;11: e0166502. https://doi.org/10.1371/journal.pone.0166502

Sijvarger CC, Gonzalez JV, Prieto A, Messmer AG, Mallimaci MC, Alonio VL, et al. [Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina]. Rev Argent Microbiol. 2006;38:19-24.

Badano I, Pedrozo RW, Ruiz Diaz LS, Galuppo JA, Picconi MA, Campos RH, et al. Human papillomavirus (HPV) detection and Papanicolaou cytology in low-resource women in Posadas city, Misiones, Argentina. Rev Argent Microbiol. 2011;43:263-7.

Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158:486-94. https://doi.org/10.1093/aje/kwg171

Murillo R, Molano M, Martinez G, Mejia JC, Gamboa O. HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infect Dis Obstet Gynecol. 2009;653598. https://doi.org/10.1155/2009/653598

Marín HM, Torres C, Deluca GD, Mbayed VA. Human papillomavirus detection in Corrientes, Argentina: High prevalence of type 58 and its phylodynamics. Rev Argent Microbiol. 2015;47:302-11. https://doi.org/10.1016/j.ram.2015.09.001

Illades-Aguiar B, Alarcon-Romero Ldel C, Antonio-Vejar V, Zamudio-Lopez N, Sales-Linares N, Flores-Alfaro E, et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intra epithelial lesions in women from Southern Mexico. Gynecol Oncol. 2010;117:291-6. https://doi.org/10.1016/j.ygyno.2010.01.036

Fajardo-Ramírez OR, Barboza-Cerda MC, Ortiz-López R, Rojas-Martínez A, Garza-Rodríguez ML, Sepúlveda-Flores A, et al. Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico. Int J Gynecol Obstet 2017;136:40-6. https://doi.org/10.1002/ijgo.12009

Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol. 1998;70:115-20. https://doi.org/10.1006/gyno.1998.5055

Gallegos-Bola-os J, Rivera-Domínguez JA, Presno-Bernal JM, Cervantes-Villagran RD. High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population. BMC Cancer 2017;17:531. https://doi.org/10.1186/s12885-017-3519-7

de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27. https://doi.org/10.1016/j.virol.2004.03.033

Callejas MD. Caracterización de la respuesta inmunitaria-inflamatoria en el cuello uterino en pacientes con displasias de cérvix. [Tesis]. Espa-a: Universidad de Alcalá. Departamento de Medicina; 2011.

Prata TT, Bonin CM, Ferreira AM, Padovani CT, Fernandes CE, Machado AP, et al. Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology. 2015;146:113-21. https://doi.org/10.1111/imm.12487

Pineda-Gómez D, Garrido E, Chávez P, Salcedo M. [Detection of microRNAs seed sequences within human papillomavirus genomes]. Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 2:S1-53.

Amaro-Filho S, Brant AC, Vidal JP, Felix SP, Bonvincino CR, Moreira MAM. 457: Diversity of methylation patterns in HPV16 LCR in cervical cancer. EJC 2014;50(5):S110-111. https://doi.org/10.1016/S0959-8049(14)50409-1

Castillo A, Wang L, Koriyama C, Eizuru Y, Jordan K, Akiba S. A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells. Open Biol. 2014;4:130119. https://doi.org/10.1098/rsob.130119

Peña N, Carrillo D, Mu-oz JP, Chnaiderman J, Urzúa U, León O, et al. Tobacco Smoke Activates Human Papillomavirus 16 p97 Promoter and Cooperates with High-Risk E6/E7 for Oxidative DNA Damage in Lung Cells. PLoS One. 2015;10: e0123029. https://doi.org/10.1371/journal.pone.0123029

World Health Organization (WHO). Cancer in the Americas, country profiles 2013. Pan-American Health Organization. Washington, DC; 2013.

Anaconda Pharma. Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts. NCT01532102: ClinicalTrials, U.S. National Institutes of Health. Biota Scientific Management Pty Ltd. 2012. [visitado 2017 Mar 29]; Disponible en: https://clinicaltrials.gov/ct2/show/record/NCT01532102

Sánchez-Anguiano LF, Alvarado-Esquivel C, Reyes-Romero MA. Carrera-Rodríguez M. Human papillomavirus infections in women seeking cervical Papanicolaou cytology of Durango, Mexico: prevalence and genotypes. BMC Infectious Diseases 2006;6:27. https://doi.org/10.1186/1471-2334-6-27

Cabrera-Gaytán D, Palacios-Rodríguez R, Guzmán-Solorio J. Sexual profile of women with cervical cytology in a first level unit. Rev Med Inst Mex Seguro Soc. 2014;52:168-75.

Navarrete TD, Donoso HF, Araya CI, Yanine MN. Frecuencia de lesiones orales en pacientes adultos VIH/SIDA del Hospital San Juan de Dios. [Tesis] Chile: Universidad de Chile, Facultad de Odontología. Departamento de Cirugía y Traumatología Maxilofacial; 2014.

Sepúlveda-Arias JC, Álvarez-Aldana A. Burden of Human Papillomavirus Infection in Latin America. En: Rodríguez-Morales AJ, ed. Current Topics in Public Health, Chapter 17. p. 359-80. https://doi.org/10.5772/53662

Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, et al. Rural-Urban Differences in Cancer Incidence and Trends in the United States. Cancer Epidemiol Biomarkers Prev. 2017. pii: cebp.0430.2017. https://doi.org/10.1158/1055-9965.EPI-17-0430

Dickson EL, Vogel RI, Luo X, Downs LS. Recent trends in type-specific HPV infection rates in the United States. Epidemiol Infect. 2015;143:1042-7. https://doi.org/10.1017/S0950268814001538

Drolet M, Brisson M, Maunsell E, Franco EL, Coutleé F, Ferenczy A, et al. The psychosocial impact of an abnormal cervical smear result. Psychooncology 2012;21:1071-81. https://doi.org/10.1002/pon.2003

Ngu SF, Wei N, Kwan TTC, Chu MMY, Tse KS, Chan KKL, et al. Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial. J Psychosom Obstet Gynaecol. 2017;10:1-10. https://doi.org/10.1080/0167482X.2017.1312335

Bosch FJ, Borrás JM, Pérez P, Company A, Sedano AM, Montserrat M. Abstract 1: A professional education programme on cervical cancer prevention: The results of an e-learning experience. Cancer Control 2014 Supplement 1: ICCC-5.

Holden DJ, Moore KS, Holliday JL. Health education for a breast and cervical cancer screening program: using the ecological model to assess local initiatives. Educ Res. 1998;13:293-9. https://doi.org/10.1093/her/13.2.293

Kornides ML, Garrell JM, Gilkey MB. Content of web-based continuing medical education about HPV vaccination. Vacciones 2017; 16;35(35 Pt B):4510-4.

McBride KR, Singh S. Predictors of Adults' Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education. Health Educ Behav. 2017:1090198117709318. https://doi.org/10.1177/1090198117709318

Kasting ML, Lake P, Vadaparampil ST. Physicians' current use and preferences for male HPV vaccine-related patient education materials. Vaccine 2017; 35: 2613–6. https://doi.org/10.1016/j.vaccine.2017.03.098

Presser BE, Katz ML, Shoben AB, Moore D, Ruffin MT, Paskett ED, et al. Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff. J Canc Educ. 2017; https://doi.org/10.1007/s13187-017-1164-0

Al-Shaikh GK, Syed SB, Fayed AA, Al-Shaikh RA, Al-Mussaed EM, Khan FH, et al. Effectiveness of health education programme: Level of knowledge about prevention of cervical cancer among Saudi female healthcare students. J Pak Med Assoc. 2017; 67:513-19.

Chigbu CO, Onyebuchi AK, Onyeka TC, Odugu BU, Dim CC. The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria. 2017;137:319-24.

Boyden LRL, Ramos JSM, Tangarife VG, Garcés-Palacio IC. Evaluation of Entertainment Education Strategies to Promote Cervical Cancer Screening and Knowledge in Colombian Women. J Canc Educ. 2017. doi: 10.1007/s13187-017-1213-8. [Epub ahead of print]. https://doi.org/10.1007/s13187-017-1213-8

Karanth SS, Lairson DR, Savas LS, Vernon SW, Fernandez ME. The cost of developing a computerized tailored interactive multimedia intervention vs. a print based Photonovella intervention for HPV vaccine education. Eval Program Plann. 2017; 63:1-6. https://doi.org/10.1016/j.evalprogplan.2017.02.009

Novoa A. Para una transformación de Profesores construida dentro de la profesión. Revista de Educación. 2009:203-18.

UNESCO/OREAL. Programas Innovadores de formación docente en América Latina y Europa. Santiago de Chile: UNESCO Ed. 2006.

Peel Health. Vaccine Preventable Disease Program. Brampton: Peel Public Health; 2012. [visitado 2017 Jul 28]; Disponible en: https://www.peelregion.ca/immunization/vaccine-preventable-diseases.asp

Project HOPE. Global NGO Project HOPE Launches Education Initiative on HPV Infection Prevention in China. Millwood, US. 2014. [visitado 2017 Mar 30]; Disponible en: http://www.projecthope.org/news-blogs/press-releases/2014/global-ngo-project-hope-7.html

Capote Negrin LG. Epidemiology of cervical cancer in Latin America. Ecancermedicalscience. 2015;9:577. https://doi.org/10.3332/ecancer.2015.577

Corusić A, Skrgatić L, Mahovlić V, Mandić V, Planinić P, Karadza M. Cervical cancer as a public health issue--what next? Coll Antropol. 2010;34:301-7.

Denny L, de Sanjose S, Mutebi M, Anderson BO, Kim J, Jeronimo J et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet 2016;21-30.

Barroeta JE, Adhikari-Guragain D, Grotkowski CE. Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology. Diagnostic Cytopathology. 2017;1–12. https://doi.org/10.1002/dc.23737

Alonso de Ruiz P, Lazcano PE, Hernández AM. Cáncer cervicouterino. Diagnóstico, prevención y control. Argentina: Editorial Médica Panamericana; 2000.

Ali H, Donovan B, Wand H, Read TRH, Reagan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013;346:f2032. https://doi.org/10.1136/bmj.f2032

Brotherton JML, Winch KL, Bicknell L, Chappell G, Saville M. HPV vaccine coverage is increasing in Australia. Med J Aust 2017; 206:262. https://doi.org/10.5694/mja16.00958

Perkins RB, Anderson BL, Sheinfeld GS, Schulkin JA. Challenges in Cervical Cancer Prevention. A Survey of U.S. Obstetrician-Gynecologists. Am J Prev Med 2013;45:175-81. https://doi.org/10.1016/j.amepre.2013.03.019

Herzog TJ, Huh WK, Einstein MH. How does public policy impact cervical screening and vaccination strategies? Ginecol Oncol. 2010;119:175-80. https://doi.org/10.1016/j.ygyno.2010.08.021

Wilson AR, Hashibe M, Bodson J, Gren LH, Taylor BA, Greenwood J, et al. Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study. BMC Women's Health 2016;16:41. https://doi.org/10.1186/s12905-016-0323-5

Beavis AL, Krakow M, Levinson K, Rositch AF. Reasons for persistent suboptimal rates of HPV vaccination in the US: Shifting the focus from sexuality to education and awareness. Gynecol Oncol 2017;145 (supp1): 4. https://doi.org/10.1016/j.ygyno.2017.03.032

Bednarczyk RA, Davis R, Ault DK, Orenstein W, Omer SB. Sexual axtivity-related outcomes after Human Papillomavirus vaccination of 11-to-12 year-old. Pediatrics 2012;130:798-805. https://doi.org/10.1542/peds.2012-1516

Markowitz LE, Dunne EF, Saraiya M, et al; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1-30.

Haug C. The Risks and Benefits of HPV Vaccination. JAMA 2009;302:795-6. https://doi.org/10.1001/jama.2009.1215

World Health Organization. 1 in 100 women in Europe will develop cervical cancer. Health Topics, Noncommunicable disease. WHO Europe; 2013. [visitado 2017 Jul 28]; Disponible en: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/news/news/2013/04/1-in-100-women-in-europe-will-develop-cervical-cancer

Rojas-Zumaran V, Moya-Salazar J. The establishment of the cytotechnologist in medical scienc0es of Peru: a profession under the thumb? Rev Latinoamer Patol Clin. 2017; 64:100-101.

Tomljenovic L, Shaw CA. Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety? Am J Public Health. 2014;102:e13-e14. https://doi.org/10.2105/AJPH.2012.300837

Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, Lewis-Bell K. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine. 2008;26:L73-L79.

Nogueira-Rodrigues A, Bukowski A, Paulino E, St Louis J, Barrichello A, Sternberg C, et al. An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation. Cancer. 2017;123:2193-9. https://doi.org/10.1002/cncr.30647

Wheeler CM. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am. 2008;35:519-36. https://doi.org/10.1016/j.ogc.2008.09.006

Moya-Salazar J, Rojas-Zumaran V. Environmental performance of xylene, hydrochloric acid and ammonia solution during pap stain for diagnosing cervical cancer. J Health Pollution. 2016;6:58-65. https://doi.org/10.5696/2156-9614-6-11.58

Papanicoloau G. A new procedure for staining vaginal smears. Science 1942; 2469:438-9. https://doi.org/10.1126/science.95.2469.438

Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA. 1989;261:737-43. https://doi.org/10.1001/jama.1989.03420050087046

Anttila A, Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009;45:2685-2708. https://doi.org/10.1016/j.ejca.2009.07.017

Levy AR, Bruen BK, Ku L. Health Care Reform and Women’s Insurance Coverage for Breast and Cervical Cancer Screening. Prev Chronic Dis 2012;9:120069.

Castle PE, de Sanjose S, Qiao YL, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012;30 Suppl 5: F117–22.

Ministerio de Salud. Manual para la implementación del test de VPH en contexto programático 1a Ed. Ciudad Autónoma de Buenos Aires: Instituto Nacional del Cáncer, 2016.

World Health Organization [Internet].WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013 [Visitado 2017 Jul 28]. Disponible en: http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf.

Moyer VA, on behalf of the US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2012;156:880-91, W312

Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516-42. https://doi.org/10.1309/AJCPTGD94EVRSJCG

Sankaranarayanan R. Screening for Cancer in Low- and Middle-Income Countries. Annals of Global Health 2014;80:412-7. https://doi.org/10.1016/j.aogh.2014.09.014

Ministerio de Salud. Guía Técnica: Guía de práctica clínica para la prevención y manejo del cáncer de cuello uterino. 1ª ed. Lima: Ministerio de Salud del Perú, 2016.

Publicado
2017-09-29
Cómo citar
1.
Moya-Salazar JJ, Rojas-Zumaran V. Tendencias en la investigación del virus de papiloma humano en Latinoamérica frente a los países de altos ingresos. Rev. Colomb. Obstet. Ginecol. [Internet]. 29 de septiembre de 2017 [citado 7 de diciembre de 2021];68(3):202-17. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/2679
Sección
Artículo de Reflexión